Regulation of coronavirus nsp15 cleavage specificity by RNA structure
Loading...
Date
Authors
Salukhe, Indraneel A.
Journal Title
Journal ISSN
Volume Title
Publisher
Abstract
SARS-CoV-2, the etiologic agent of the COVID-19 pandemic, has had a significantimpact on global public health. However, SARS-CoV-2 is only one of multiple pathogenic
human coronaviruses (CoVs) to have emerged since the turn of the century. CoVs encode
for several nonstructural proteins (nsps) that are essential for viral replication and
pathogenesis. Among them is nsp15, a uridine-specific viral endonuclease that is
important in evading the host immune response and promoting viral replication. Despite
the established endonuclease function of nsp15, other determinants of its cleavage
specificity have only recently begun to be investigated. In this study we investigate the
role of RNA secondary structure in SARS-CoV-2 nsp15 endonuclease activity.
We identified regions of differing predicted RNA secondary structure across the
SARS-CoV-2 genome. Using a series of in vitro endonuclease assays, we observed that
thermodynamically stable RNA structures were protected from nsp15 cleavage relative to
RNAs lacking stable structure. We leveraged the s2m RNA from the SARS-CoV-1 3’UTR
as a model RNA structure for our studies as it adopts a well-defined structure with several
uridines, two of which are unpaired and thus highly probable targets for nsp15 cleavage.
We found that SARS-CoV-2 nsp15 specifically cleaves s2m at the unpaired uridine within
the pentaloop of the RNA. Further investigation revealed that the position of this uridine
also impacted nsp15 cleavage efficiency suggesting that positioning within the pentaloop
is necessary for optimal presentation of the scissile uridine and alignment within the
nsp15 catalytic pocket. Our findings indicate that RNA secondary structure is an important
determinant of nsp15 cleavage and provides insight into the molecular mechanisms of
RNA recognition by nsp15. Understanding the broader implications of nsp15 activity will
provide further insight not only into CoV biology but also into drug development against
nsp15.
Description
Thesis (Ph.D.)--University of Washington, 2023
